Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00344981 · ClinicalTrials.gov registry record · NA
Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression
A NA study of HIV Infections and AIDS, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT00344981: Completed NA study of HIV Infections and AIDS, sponsored by University of Maryland, Baltimore.
NCT00344981 is a NA study of HIV Infections and AIDS that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 9 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00344981, a NA study of HIV Infections and AIDS, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Study Hypothesis Evaluation of the durability of the combination Tenofovir and Hydroxyurea to maintain viral suppression below 50 copies/ml in volunteers who have achieved viral suppression on a standard HAART regimen.
Primary Outcome
Viral load measurements will be done throughout the study to monitor for viral suppression
Conditions Studied
Interventions
- DRUG Hydroxyurea
- DRUG Tenofovir
Study Locations (1)
Maryland
- University of Maryland, Institute of Human Virology - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-11 |
| Phase | NA |
What the finished NCT00344981 record still lists
NCT00344981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Hydroxyurea is the first listed.
NCT00344981 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00344981 about?
NCT00344981 is a clinical study titled "Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression". Study Hypothesis Evaluation of the durability of the combination Tenofovir and Hydroxyurea to maintain viral suppression below 50 copies/ml in volunteers who have achieved viral suppression on a standard HAART regimen.
What is the current status of trial NCT00344981?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2003-06. Estimated completion is 2006-11.
What conditions does trial NCT00344981 study?
This clinical trial studies the following conditions: HIV Infections, AIDS.
What interventions are being tested in trial NCT00344981?
The interventions under investigation include: Hydroxyurea (DRUG), Tenofovir (DRUG).
Who is sponsoring clinical trial NCT00344981?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00344981 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00344981's enrollment target sits among peer trials
9 530th of 542 higher than 11 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia